Atlas Trials

Invasive Bladder Cancer

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Invasive Bladder Cancer

RecordFirmDate
Nordic Cystectomy Study III - Transfusion (NCT04537221)Turku University Hospital2020-09-30
Nordic Cystectomy Study I - Neutrophil-lymphocyte Ratio (NLR) (NCT04523025)Turku University Hospital2020-08-30
Nordic Cystectomy Study II - Albumin (NCT04523038)Turku University Hospital2020-08-30
Testing the Utilization of a Mobile Health App for Patients Undergoing Cystectomy Surgery for Bladder Cancer (NCT03862105)UNC Lineberger Comprehensive Cancer Center2019-03-25
A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study (NCT03844256)Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2019-01-07
A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer (NCT03498196)Baylor College of Medicine2018-12-14
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach (NCT03702179)Spanish Oncology Genito-Urinary Group2018-11-19
HIPEC After Radical Cystectomy for High Risk Bladder Cancer (NCT03514888)Weill Medical College of Cornell University2018-04-19
Intravenous Lidocaine for Cystectomy Procedures (NCT02924480)CAMC Health System2016-10-12
Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer (NCT02560636)Royal Marsden NHS Foundation Trust2016-06-06
Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin (NCT02030574)Brown University2014-07-01
MRI and Bladder Cancer Chemotherapy (NCT01922232)NYU Langone Health2013-08-01

Track Invasive Bladder Cancer automatically

Every clearance here is in the API, with alerts when new ones post.